Stifel maintains $28 target on Phathom Pharmaceuticals stock
Stifel analysts have maintained a Buy rating and a $28.00 price target for Phathom Pharmaceuticals (NASDAQ:PHAT), focusing on the company's recent developments. Currently trading at $5.59, ...
Earnings call transcript: Iterum Therapeutics reports Q4 2024 results and stock surges
Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...
Eton Pharmaceuticals granted new patent from USPTO
Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office has granted the company U.S. Patent No. 12,214,010, ...
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange ...
Clearwater County Historical Society to hold used book sale
The Clearwater County Historical Society will hold a used book sale Feb. 11-19, at the History Center in Shevlin. The sale will run from 10 a.m. to 4 p.m. Tuesday through Friday, 10 a.m. to 2 p.m. on ...
verywellhealth2d
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer Type
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
CNET3d
Banned but Not Gone: Learn 9 of the Most Popular Foods Containing Red Dye No. 3
The state of California banned the Red No. 3 dye and three other food additives in 2023, which gave manufacturers until 2027 ...
Malaysian Reserve5d
WIT Legal Releases 2nd Annual Report on Trends in Hatch-Waxman Litigation
The new report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue throughout ...